Analysis Coloplast A/S (0QBO)
6/2/2024
Analysis of Coloplast A/S (0QBO)
Coloplast A/S is a Danish company that specializes in the development and marketing of medical devices and services. Looking at the recent stock data, we can see that the price has been fluctuating between 771.00 and 880.30.Key technical indicators such as the Relative Strength Index (RSI), Moving Average Convergence Divergence (MACD), and Moving Averages (MA) provide valuable insights into the stock's performance.
The RSI indicator is showing values ranging from 25.89 to 55.90, indicating some volatility in the stock price. The MACD indicator is negative, suggesting a bearish trend, but the MACD histogram shows some positive momentum.
The Moving Averages (SMA, EMA, WMA) are also fluctuating, indicating uncertainty in the stock's direction.
Overall, it seems that Coloplast A/S is experiencing some volatility, and investors should closely monitor the technical indicators for potential trading opportunities.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results for January 31, 2025, were released after hours. The results for October 31, 2024, were not provided at the time. The results for August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio. The company's market capitalization and enterprise value are substantial, with moderate price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes beta, moving averages, and the range of prices over the past year.
Lastly, dividends and splits information shows the company's dividend history, payout ratio, and dividend yield metrics. The company has a regular dividend payment schedule and has undergone a stock split in the past.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate growth expected in both the quarterly and annual sales figures.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant increase in growth rate from the past 5 years to the next 5 years. The growth rates for the current and next quarter are the same, indicating a steady growth pattern in the short term. The next year is expected to see a higher growth rate compared to the current year.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the majority clustering around the median and average values. The current price is below both the median and average forecast, suggesting that analysts are generally optimistic about the security's future performance. However, it's important to consider other factors and do further research before making any investment decisions.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the past four fiscal years.
2. The EBIT (Earnings Before Interest and Taxes) and EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) have also shown a positive trend, indicating healthy operational performance.
3. Net income has been growing consistently, reflecting the company's profitability.
4. Despite fluctuations in other income and expenses, the company has managed to maintain a strong financial position.
5. The basic and diluted earnings per share (EPS) have remained relatively stable over the years.
6. The company has effectively managed its operating expenses in relation to its revenue growth.
7. The non-operating interest income and expenses have had a minor impact on the overall financial performance.
8. The number of basic and diluted shares outstanding has remained relatively constant.
9. The company's gross profit margin has been relatively stable, indicating efficient cost management.
Overall, the financial performance of the company, as indicated by its revenue figures, seems to be on a positive trajectory with consistent growth in sales and profitability.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in different areas that may require further analysis.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Year Ago EPS: $1.17
- Number of Analysts: 27
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Year Ago EPS: $1.35
- Number of Analysts: 26
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Year Ago EPS: $5.67
- Number of Analysts: 40
4. Next Year (as of September 30, 2025):
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Year Ago EPS: $6.10
- Number of Analysts: 40
Based on these estimates, we can see a generally positive trend in the expected earnings per share both for the upcoming quarters and the next year compared to the previous year's performance. This indicates a growth trajectory in the company's earnings as projected by analysts.
MACD of 0QBO
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
